Category: Uncategorized

COMPLEMENTARY NICOTINE. "The market for e-cigarettes is split between smokers trying to kick their smoking habits and those looking for a complementary product to smoking, for example where cigarette smoking is banned." https://lnkd.in/dypBckx View in LinkedIn

JAPAN TOBACCO BUYS WATERPIPE TOBACCO COMPANY, 2012. The Waterpipe company sells about 24,000 tons of product a year, equivalent to 24 billion cigarettes. Equivalent in weight to 12,000 cars. https://www.jt.com/investors/media/press_releases/2012/pdf/20121116_04.pdf View in LinkedIn

MOVE TOWARDS E-CIGARETTES. "The year 2013 saw a flurry of tobacco company investment in e-cigarettes, both in the UK and in the US. This trend continued into 2014. These included deals and initiatives by BAT, Lorillard, Japan Tobacco, Imperial, Philip Morris, and RJ Reynolds." https://lnkd.in/dqBuGgc View in LinkedIn

A THIRD CASE: Procorida AB was the holding company for Pharmacia AB (Swedish Tobacco Company) and Pinkerton Tobacco Company. "By ... sharing technology among its pharmaceutical and tobacco holdings, Procordia AB had the potential to benefit financially from creating an addiction through tobacco sales that could then be treated" by NRTs. https://lnkd.in/d8VgiAE View in LinkedIn

"A SECOND CASE STUDY documents exchanges between CIBA-Geigy (now Novartis) and Phillip Morris. CIBA-Geigy had been a "major supplier" of pesticides to Phillip Morris ... but when CIBA-Geigy released its nicotine patch Habitrol in 1991, the tobacco company was moved to "help" CIBA-Geigy "devise more appropriate advertising" for the product." https://lnkd.in/d8VgiAE View in LinkedIn

"ONE CASE STUDY showed that Marion Merrell Dow, a subsidiary of Dow Chemical Company and manufacturer of Nicorette® gum, canceled its Smoking Cessation Newsletter to physicians after tobacco giant Phillip Morris threatened to cancel its regular purchase of humectants from Dow Chemical." http://www.medscape.com/viewarticle/786012 View in LinkedIn

CANCER RESEARCH UK commissioned a thorough study about the changing tobacco landscape with e-cigarettes, which will be abstracted in part herein, but is worth a careful read. https://lnkd.in/d-5YcyD View in LinkedIn

TOBACCO MANIPULATION OF PHARMA'S NRT MESSAGE. Three case studies of the influence of tobacco companies on the NRT messaging by pharma, due to their often hidden lateral financial ties. Snippets of these three cases follow. http://www.medscape.com/viewarticle/786012 View in LinkedIn

ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS): "The use of ENDS is apparently booming. It is estimated that in 2014 there were 466 brands and that in 2013 US$ 3 billion was spent on ENDS globally. Sales are forecasted to increase by a factor of 17 by 2030." The WHO Report 2014. https://lnkd.in/d2e7-yr View in LinkedIn

"CORPORATE DIVERSIFICATION of companies such as Procordia AB has allowed well-hidden financial ties between pharmaceutical companies and the tobacco industry to foster collaboration among companies. . . . We argue that it is not an acceptable conflict of interest for a company to profit both from selling addictive tobacco products and the drugs to treat the addiction." http://www.medscape.com/viewarticle/786012 View in LinkedIn